IGF-1 release kinetics from chitosan microparticles fabricated using environmentally benign conditions

Materials Science and Engineering C

Volumn 42, Issue , 2014, Pages 506-516

  Mantripragada, Venkata P ^a   Jayasuriya, Ambalangodage C ^a,b  

^a Toledo   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

Chitosan; Controlled release; Degradation; IGF 1; In vitro; Microparticles

Indexed keywords

ACETONE; BIOACTIVITY; BIOCOMPATIBILITY; CHITOSAN; CROSSLINKING; DEGRADATION; EMULSIFICATION; FABRICATION; ORGANIC SOLVENTS; REPAIR;

CHITOSAN MICROPARTICLES; CONTROLLED RELEASE; ENCAPSULATION EFFICIENCY; ENVIRONMENTAL CONDITIONS; ENVIRONMENTALLY BENIGN; IGF-1; IN-VITRO; MICRO-PARTICLES;

ENCAPSULATION;

CHITOSAN; DELAYED RELEASE FORMULATION; POLYPHOSPHATE; SOMATOMEDIN C; TRIPHOSPHORIC ACID;

CELL ADHESION; CELL LINE; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; HUMAN; KINETICS; PH; PHARMACOKINETICS; REAL TIME POLYMERASE CHAIN REACTION; TEMPERATURE;

CELL ADHESION; CELL LINE; CELL SURVIVAL; CHITOSAN; DELAYED-ACTION PREPARATIONS; HUMANS; HYDROGEN-ION CONCENTRATION; INSULIN-LIKE GROWTH FACTOR I; KINETICS; POLYPHOSPHATES; REAL-TIME POLYMERASE CHAIN REACTION; TEMPERATURE;

EID: 84903135861     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2014.05.068     Document Type: Article

References (57)

1. C.D. Hoemann, J. Sun, A. Legare, M.D. McKee, and M.D. Buschmann Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle Osteoarthr. Cartil. 13 2005 318 329
2. S.V. Madihally, and H.W.T. Matthew Porous chitosan scaffolds for tissue engineering Biomaterials 20 1999 1133 1142
3. X.X. Shao, and C.J. Hunter Developing an alginate/chitosan hybrid fiber scaffold for annulus fibrosus cells J. Biomed. Mater. Res. A 82A 2007 701 710
4. H. Liu, and C. Gao Preparation and properties of ionically cross-linked chitosan nanoparticles Polym. Adv. Technol. 20 2009 613 619
5. M. Biondi, F. Ungaro, F. Quaglia, and P.A. Netti Controlled drug delivery in tissue engineering Adv. Drug Deliv. Rev. 60 2008 229 242
6. I.D. Dinbergs, L. Brown, and E.R. Edelman Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions J. Biol. Chem. 271 1996 29822 29829
7. K. Moore, M. MacSween, and M. Shoichet Immobilized concentration gradients of neurotrophic factors guide neurite outgrowth of primary neurons in macroporous scaffolds Tissue Eng. 12 2006 267 278
8. L. Liu, and C.A. Parent Review series: TOR kinase complexes and cell migration J. Cell Biol. 194 2011 815 824
9. A. Giustina, G. Mazziotti, and E. Canalis Growth hormone, insulin-like growth factors, and the skeleton Endocr. Rev. 29 2008 535 559
10. S. Yakar, and C.J. Rosen From mouse to amn: redefining the role of insulin-like growth factor-I in the acquisition of bone mass Exp. Biol. Med. 228 2003 245 252
11. R. Rizzoli, M.L. Bianchi, M. Garabadian, H.A. McKay, and L.A. Moreno Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescent and the elderly Bone 46 2010 294 305
12. C. Ohlsson Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study J. Bone Miner. Metab. 26 2008 159 164
13. C. Ohlsson The role of liver derived insulin-like growth factor-I Endocr. Rev. 30 2009 494 535
14. A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease Endocr. Rev. 30 2009 586 623
15. J.P. Bonjour, T. Chavalley, S. Ferrari, and R. Rizzoli The importance and relevance of peak bone mass in the prevalence of osteoporosis Salud Publica Mex. 51 2009 S5 S17
16. E. Ziv, and D. Hu Genetic variation in insulin/IGF-1 signaling pathways and longetivity Ageing Res. Rev. 10 2011 201 204
17. D. Edwall, P.T. Prisell, A. Levinovitz, E. Jennische, and G. Norstedt Expression of insulin-like growth factor-I messenger ribonucleic acid in regenerating bone after fracture: influence of indomethacin J. Bone Miner. Res. 7 1992 207 213
18. A.C. Jayasuriya, and A. Bhat Optimization of scaled up chitosan microparticles Biomed. Mater. 4 2009 5 12
19. E. Khor, and L.Y. Lim Implantable applications of chitin and chitosan Biomaterials 24 2003 2339 2349
20. T. Jiang, S.G. Kumbar, L.S. Nair, and C.T. Laurencin Biologically active chitosan systems for tissue engineering and regenerative medicine Curr. Top. Med. Chem. 8 2008 354 364
21. H.H. Chia, T.S. Chung, and Y.Y. Yang Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method J. Control. Release 69 2000 81 96
22. G. Crotts, and T.G. Park Preparation of porous and nonporous biodegradable polymeric hollow microspheres J. Control. Release 35 1995 91 105
23. K. Yamaguchi, and J.M. Anderson In vivo biocompatibility studies of medisorb 65/35 D, L-lactide/glycolide copolymer microspheres J. Control. Release 24 1993 81 93
24. T. Jiang, S.P. Nukavarapu, M. Deng, E. Jabbarzadeh, D.K. Michelle, S.B. Doty, W.I. Abdel-Fattah, and C.T. Laurencin Chitosan-poly(lactide-co-glycolide) microsphere-based scaffolds for bone tissue engineering: in vitro degradation and in vivo bone regeneration studies Acta Biomater. 6 2010 3457 3470
25. K. Liburdi, R. Straniero, I. Benucci, A. Maria, V. Garzillo, and M. Esti Lysozyme immobilized on micro-sized magnetic particles: kinetic parameters at wine pH Appl. Biochem. Biotechnol. 166 2012 1736 1746
26. X.Z. Shu, and K.J. Zhu The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release Eur. J. Pharm. Biopharm. 54 2002 235 243
27. P. Tayalia, and D.J. Mooney Controlled growth factor delivery for tissue engineering Adv. Mater. 21 2009 3269 3285
28. M.J. Kanczler, J. Barry, P. Ginty, S.M. Howdle, K.M. Shakesheff, and R.O.C. Oreffo Supercritical carbon dioxide generated vascular endothelial growth factor encapsulated poly(DL-lactic acid) scaffolds induce angiogenesis in vitro Biochem. Biophys. Res. Commun. 352 2007 135-14
29. J.L. Drury, and D.J. Mooney Hydrogels for tissue engineering: scaffold design variables and applications Biomaterials 24 2003 4337 4351
30. K.Y. Lee, and D.J. Mooney Hydrogels for tissue engineering Chem. Rev. 101 2001 1869 1879
31. J.E. Lee, S.E. Kim, I.C. Kwon, H.J. Ahn, H. Cho, S.H. Lee, H.J. Kim, S.C. Seong, and M.C. Lee Effects of a chitosan scaffold containing TGF-β1 encapsulated chitosan microspheres on in vitro chondrocyte culture Artif. Organs 28 2004 829 839
32. F.M. Chen, Y.M. Zhao, H. Wu, Z.H. Deng, Q.T. Wang, and Y. Jin Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres J. Control. Release 114 2006 209 222
33. S. Kim, Y. Kang, C.A. Krueger, M. Sen, J.B. Holcomb, D. Chen, J.C. Wenke, and Y. Yang Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation Acta Biomater. 8 2012 1768 1777
34. R.R. Chen, E.A. Silva, W.W. Yuen, A.A. Brock, C. Fischbach, A.S. Lin, R.E. Guldberg, and D.J. Mooney Integrated approach to designing growth factor delivery systems FASEB J. 21 2007 3896
35. L. Xian, X. Wu, L. Pang, M. Lou, C.J. Rosen, T. Qiu, J. Crane, F. Frassica, L. Zhang, J.P. Rodriguez, X. Jia, S. Yakar, S. Xuan, A. Efstratiadis, M. Wan, and X. Cao Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells Nat. Med. 18 2012 1095 1101
36. A. Di Martino, M. Sittinger, and M.V. Risbud Chitosan: a versatile biopolymer for orthopaedic tissue-engineering Biomaterials 26 2005 5983 5990
37. Z. Ma, H.H. Yeoh, and L.E. Lim Formulation pH modulates the interaction of insulin with chitosan microparticles J. Pharm. Sci. 91 2002 1396 1404
38. K.C. Gupta, and M.N.V.R. Kumar Drug release behavior of beads and microgranules of chitosan Biomaterials 21 2000 1115 1119
39. J.C. Bradley, J. Simoni, R.H. Bradley, D.L. McCartney, and S.M. Brown Time and temperature dependent stability of growth factor peptides in human autologous serum eye drops Cornea 28 2009 200 205
40. A.L. Berrier, and K.M. Yamada Cell-matrix adhesion J. Cell. Physiol. 213 2007 565 573
41. E. Cukierman, R. Pankov, D.R. Stevens, and K.M. Yamada Taking cell-matrix adhesion to the third dimension Science 294 2001 1708 1712
42. X. Lu, and Y. Leng Quantitative analysis of osteoblast behavoiur on microgrooved hydroxyapatite and titanium substrata J. Biomed. Mater. Res. A 66 2003 677 687
43. K. Kieswetter, Z. Schwartz, T.W. Hummert, D.L. Cochran, J. Simpson, D.D. Dean, and B.D. Boyan Surface roughness modulates the local production of growth factors and cytokines by osteoblast like MG-63 cells J. Biomed. Mater. Res. 32 1996 55 63
44. D.L. Nettles, S.H. Elder, and J.A. Gilbert Potential use of chitosan as a cell scaffold material for cartilage tissue engineering Tissue Eng. 8 2002 1009 1016
45. W. Zhang, X. Shen, C. Wan, Q. Zhao, L. Zhang, Q. Zhou, and L. Deng Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: signaling via Akt and ERK Cell Biochem. Funct. 30 2012 297 302
46. M. Zhang, S. Xuan, M.L. Bouxsein, D. von Stechow, N. Akeno, and M.C. Faugere Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization J. Biol. Chem. 277 2002 44005 44012
47. J. Jiang, A.C. Lichtler, G.A. Gronowicz, D.J. Adams, S.H. Clark, and C.J. Rosen Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling Bone 39 2006 494 504
48. P. Ducy, M. Starbuck, M. Priemel, J. Shen, G. Pinero, V. Geoffroy, M. Amling, and G. Karsenty A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development Genes Dev. 13 1999 1025 1036
49. T.E. Adams, V.C. Epa, T.P. Garrett, and C.W. Ward Structure and function of the type 1 insulin-like growth factor receptor Cell. Mol. Life Sci. 57 2000 1050 1093
50. J.G. Shelton, L.S. Steelman, E.R. White, and J.A. McCubrey Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells Cell Cycle 3 2004 372 379
51. C.M. Taniguchi, B. Emanuelli, and C.R. Kahn Critical nodes in signaling pathways: insights into insulin action Nat. Rev. Mol. Cell Biol. 7 2006 85 96
52. K. Nakashima, and B. de Crombrugghe Transcriptional mechanisms in osteoblast differentiation and bone formation Trends Genet. 19 2003 458 466
53. T. Fujita, Y. Azuma, R. Fukuyama, Y. Hattori, C. Yoshida, M. Koida, K. Ogita, and T. Komori Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling J. Cell Biol. 166 2004 85 95
54. A. Aryaei, A.H. Jayatissa, and A.C. Jayasuriya Mechanical and biological properties of chitosan/carbon nanotube nanocomposite films J. Biomed. Mater. Res. A 2013 Sep 24. 10.1002/jbm.a.34942 [Epub ahead of print]
55. M.B. Dreifke, N.A. Ebraheim, and A.C. Jayasuriya Investigation of potential injectable polymeric biomaterials for bone regeneration J. Biomed. Mater. Res. A 101 2013 2436 2447
56. A. Aryaei, A.H. Jayatissa, and A.C. Jayasuriya Nano and micro mechanical properties of uncross-linked and cross-linked chitosan films J. Mech. Behav. Biomed. Mater. 5 2012 82 89
57. A. Bhat, M.B. Dreifke, Y. Kandimalla, C. Gomez, N.A. Ebraheim, and A.C. Jayasuriya Evaluation of cross-linked chitosan microparticles for bone regeneration J. Tissue Eng. Regen. Med. 4 2010 532 542